Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis
- PMID: 35121209
- PMCID: PMC8798975
- DOI: 10.1016/j.jns.2022.120162
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis
Abstract
Importance: Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system. These symptoms are yet to be synthesized and quantified via meta-analysis.
Objective: To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.
Data sources: A systematic search of PubMed, EMBASE, Web of Science, Google Scholar and Scopus was conducted for studies published between January 1st, 2020 and August 1st, 2021. The systematic review was guided by Preferred Reporting Items for Systematic Review and Meta-Analyses.
Study selection: Studies were included if the length of follow-up satisfied the National Institute for Healthcare Excellence (NICE) definition of post-COVID-19 syndrome (symptoms that develop or persist ≥3 months after the onset of COVID-19). Additional criteria included the reporting of neurological or neuropsychiatric symptoms in individuals with COVID-19.
Data extraction and synthesis: Two authors independently extracted data on patient characteristics, hospital and/or ICU admission, acute-phase COVID-19 symptoms, length of follow-up, and neurological and neuropsychiatric symptoms.
Main outcome(s) and measure(s): The primary outcome was the prevalence of neurological and neuropsychiatric symptoms reported ≥3 months post onset of COVID-19. We also compared post-COVID-19 syndrome in hospitalised vs. non-hospitalised patients, with vs. without ICU admission during the acute phase of infection, and with mid-term (3 to 6 months) and long-term (>6 months) follow-up.
Results: Of 1458 articles, 19 studies, encompassing a total of 11,324 patients, were analysed. Overall prevalence for neurological post-COVID-19 symptoms were: fatigue (37%, 95% CI: 24%-50%), brain fog (32%, 9%-55%), memory issues (27%, 18%-36%), attention disorder (22%, 10%-34%), myalgia (18%, 4%-32%), anosmia (12%, 7%-17%), dysgeusia (11%, 4%-17%) and headache (10%, 1%-21%). Neuropsychiatric conditions included sleep disturbances (31%, 18%-43%), anxiety (23%, 13%-33%) and depression (12%, 7%-21%). Neuropsychiatric symptoms substantially increased in prevalence between mid- and long-term follow-up. Compared to non-hospitalised patients, patients hospitalised for acute COVID-19 had reduced frequency of anosmia, anxiety, depression, dysgeusia, fatigue, headache, myalgia, and sleep disturbance at three (or more) months post-infection. Conversely, hospital admission was associated with higher frequency of memory issues (OR: 1.9, 95% CI: 1.4-2.3). Cohorts with >20% of patients admitted to the ICU during acute COVID-19 experienced higher prevalence of fatigue, anxiety, depression, and sleep disturbances than cohorts with <20% of ICU admission.
Conclusions and relevance: Fatigue, cognitive dysfunction (brain fog, memory issues, attention disorder) and sleep disturbances appear to be key features of post-COVID-19 syndrome. Psychiatric manifestations (sleep disturbances, anxiety, and depression) are common and increase significantly in prevalence over time. Randomised controlled trials are necessary to develop intervention strategy to reduce disease burden.
Keywords: COVID-19; ICU; Long-COVID; Long-Haulers; Neuro-COVID-19; PCNS; Post-COVID-19 neurological syndrome; Post-COVID-19 syndrome; SARS-CoV-2.
Copyright © 2022 Elsevier B.V. All rights reserved.
Figures
Comment in
-
Call for correction: Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.J Neurol Sci. 2022 May 15;436:120232. doi: 10.1016/j.jns.2022.120232. Epub 2022 Mar 19. J Neurol Sci. 2022. PMID: 35339066 Free PMC article. No abstract available.
Similar articles
-
Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.Cureus. 2022 Sep 28;14(9):e29694. doi: 10.7759/cureus.29694. eCollection 2022 Sep. Cureus. 2022. PMID: 36321004 Free PMC article. Review.
-
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.Cephalalgia. 2021 Nov;41(13):1332-1341. doi: 10.1177/03331024211020404. Epub 2021 Jun 16. Cephalalgia. 2021. PMID: 34134526 Free PMC article.
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
-
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis.Neuroepidemiology. 2024;58(2):120-133. doi: 10.1159/000536352. Epub 2024 Jan 25. Neuroepidemiology. 2024. PMID: 38272015
-
Neurological Sequelae of COVID-19.J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077. J Integr Neurosci. 2022. PMID: 35633158 Review.
Cited by
-
Prevalence and factors influencing long COVID among primary healthcare workers after epidemic control policy adjustment in Jiangsu, China.BMC Infect Dis. 2024 Sep 12;24(1):964. doi: 10.1186/s12879-024-09764-5. BMC Infect Dis. 2024. PMID: 39266971 Free PMC article.
-
Characterization of postintensive care syndrome in a prospective cohort of survivors of COVID-19 critical illness: a 12-month follow-up study.Can J Anaesth. 2024 Sep 9. doi: 10.1007/s12630-024-02811-4. Online ahead of print. Can J Anaesth. 2024. PMID: 39251486 English.
-
A Bibliometric Analysis of Post-COVID-19 Syndrome.J Multidiscip Healthc. 2024 Aug 29;17:4213-4221. doi: 10.2147/JMDH.S477256. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39224486 Free PMC article.
-
A Journey Through Grief: Experiences of Loss Among Patients With Long COVID.J Patient Exp. 2024 Aug 30;11:23743735241272267. doi: 10.1177/23743735241272267. eCollection 2024. J Patient Exp. 2024. PMID: 39221194 Free PMC article.
-
Resting-state neural dynamics changes in older adults with post-COVID syndrome and the modulatory effect of cognitive training and sex.Geroscience. 2024 Aug 29. doi: 10.1007/s11357-024-01324-8. Online ahead of print. Geroscience. 2024. PMID: 39210163
References
-
- Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26(7):1017–1032. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous